» Articles » PMID: 37508489

CD10-Bound Human Mesenchymal Stem/Stromal Cell-Derived Small Extracellular Vesicles Possess Immunomodulatory Cargo and Maintain Cartilage Homeostasis Under Inflammatory Conditions

Overview
Journal Cells
Publisher MDPI
Date 2023 Jul 29
PMID 37508489
Authors
Affiliations
Soon will be listed here.
Abstract

The onset and progression of human inflammatory joint diseases are strongly associated with the activation of resident synovium/infrapatellar fat pad (IFP) pro-inflammatory and pain-transmitting signaling. We recently reported that intra-articularly injected IFP-derived mesenchymal stem/stromal cells (IFP-MSC) acquire a potent immunomodulatory phenotype and actively degrade substance P (SP) via neutral endopeptidase CD10 (neprilysin). Our hypothesis is that IFP-MSC robust immunomodulatory therapeutic effects are largely exerted via their CD10-bound small extracellular vesicles (IFP-MSC sEVs) by attenuating synoviocyte pro-inflammatory activation and articular cartilage degradation. Herein, IFP-MSC sEVs were isolated from CD10High- and CD10Low-expressing IFP-MSC cultures and their sEV miRNA cargo was assessed using multiplex methods. Functionally, we interrogated the effect of CD10High and CD10Low sEVs on stimulated by inflammatory/fibrotic cues synoviocyte monocultures and cocultures with IFP-MSC-derived chondropellets. Finally, CD10High sEVs were tested in vivo for their therapeutic capacity in an animal model of acute synovitis/fat pad fibrosis. Our results showed that CD10High and CD10Low sEVs possess distinct miRNA profiles. Reactome analysis of miRNAs highly present in sEVs showed their involvement in the regulation of six gene groups, particularly those involving the immune system. Stimulated synoviocytes exposed to IFP-MSC sEVs demonstrated significantly reduced proliferation and altered inflammation-related molecular profiles compared to control stimulated synoviocytes. Importantly, CD10High sEV treatment of stimulated chondropellets/synoviocyte cocultures indicated significant chondroprotective effects. Therapeutically, CD10High sEV treatment resulted in robust chondroprotective effects by retaining articular cartilage structure/composition and PRG4 (lubricin)-expressing cartilage cells in the animal model of acute synovitis/IFP fibrosis. Our study suggests that CD10High sEVs possess immunomodulatory miRNA attributes with strong chondroprotective/anabolic effects for articular cartilage in vivo. The results could serve as a foundation for sEV-based therapeutics for the resolution of detrimental aspects of immune-mediated inflammatory joint changes associated with conditions such as osteoarthritis (OA).

Citing Articles

Mesenchymal stromal cells-derived extracellular vesicles in cartilage regeneration: potential and limitations.

Pineiro-Ramil M, Gomez-Seoane I, Rodriguez-Cendal A, Fuentes-Boquete I, Diaz-Prado S Stem Cell Res Ther. 2025; 16(1):11.

PMID: 39849578 PMC: 11755911. DOI: 10.1186/s13287-025-04135-6.


Purification of mesenchymal stromal cell-derived small extracellular vesicles using ultrafiltration.

Lei R, Ren S, Ye H, Cui Z J Extracell Biol. 2025; 4(1):e70030.

PMID: 39830832 PMC: 11739894. DOI: 10.1002/jex2.70030.


Mesenchymal stem cell-derived extracellular vesicles for human diseases.

Zhang X, Che X, Zhang S, Wang R, Li M, Jin Y Extracell Vesicles Circ Nucl Acids. 2024; 5(1):64-82.

PMID: 39698413 PMC: 11648454. DOI: 10.20517/evcna.2023.47.


The Use of Mesenchymal Stem/Stromal Cell-Derived Extracellular Vesicles in the Treatment of Osteoarthritis: Insights from Preclinical Studies.

Jones M, Jones E, Kouroupis D Bioengineering (Basel). 2024; 11(10).

PMID: 39451337 PMC: 11504680. DOI: 10.3390/bioengineering11100961.


Human mesenchymal stem/stromal cell-derived extracellular vesicle transport in meniscus fibrocartilage.

Schwartz G, Rana S, Jackson A, Lenero C, Best T, Kouroupis D J Orthop Res. 2024; 43(2):457-465.

PMID: 39396193 PMC: 11703673. DOI: 10.1002/jor.25993.


References
1.
van den Bosch M, Blom A, van Lent P, van Beuningen H, Blaney Davidson E, van der Kraan P . Canonical Wnt signaling skews TGF-β signaling in chondrocytes towards signaling via ALK1 and Smad 1/5/8. Cell Signal. 2014; 26(5):951-8. DOI: 10.1016/j.cellsig.2014.01.021. View

2.
Battula V, Treml S, Bareiss P, Gieseke F, Roelofs H, de Zwart P . Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica. 2008; 94(2):173-84. PMC: 2635396. DOI: 10.3324/haematol.13740. View

3.
Sturiale S, Barbara G, Qiu B, Figini M, Geppetti P, Gerard N . Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A. 1999; 96(20):11653-8. PMC: 18089. DOI: 10.1073/pnas.96.20.11653. View

4.
Styczynska-Soczka K, Amin A, Hall A . Cell-associated type I collagen in nondegenerate and degenerate human articular cartilage. J Cell Physiol. 2021; 236(11):7672-7681. DOI: 10.1002/jcp.30418. View

5.
Rizzo M, Best T, Huard J, Philippon M, Hornicek F, Duan Z . Therapeutic Perspectives for Inflammation and Senescence in Osteoarthritis Using Mesenchymal Stem Cells, Mesenchymal Stem Cell-Derived Extracellular Vesicles and Senolytic Agents. Cells. 2023; 12(10). PMC: 10217382. DOI: 10.3390/cells12101421. View